4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-238995
Chief Legal Officer sold 2,408 shares at $10.00 ($24,080)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bizily Scott · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-09 | Sale : show line 1 in the form 10b5-1 | −2,408 | $10.00 | $24,080 | 5,188 | D |
| Open-market sales · 2,408 sh · avg $10.00 · $24,080 | ||||||
Loading xslF345X05/ownership.xml…